Update Review about Metabolic Myopathies
Open Access
Abstract
The aim of this review is to summarize and discuss recent findings and new insights in the etiology and phenotype of metabolic myopathies. The review relies on a systematic literature review of recent publications. Metabolic myopathies are a heterogeneous group of disorders characterized by mostly inherited defects of enzymatic pathways involved in muscle cell metabolism. Metabolic myopathies present with either permanent (fixed) or episodic abnormalities, such as weakness, wasting, exercise-intolerance, myalgia, or an increase of muscle breakdown products (creatine-kinase, myoglobin) during exercise. Though limb and respiratory muscles are most frequently affected, facial, extra-ocular, and axial muscles may be occasionally also involved. Age at onset and prognosis vary considerably. There are multiple disease mechanisms and the pathophysiology is complex. Genes most recently related to metabolic myopathy include PGM1, GYG1, RBCK1, VMA21, MTO1, KARS, and ISCA2. The number of metabolic myopathies is steadily increasing. There is limited evidence from the literature that could guide diagnosis and treatment of metabolic myopathies. Treatment is limited to mainly non-invasive or invasive symptomatic measures. In conclusion, the field of metabolic myopathies is evolving with the more widespread availability and application of next generation sequencing technologies worldwide. This will broaden the knowledge about pathophysiology and putative therapeutic strategies for this group of neuromuscular disorders.Keywords
This publication has 92 references indexed in Scilit:
- Bulbar muscle weakness and fatty lingual infiltration in glycogen storage disorder type IIIaMolecular Genetics and Metabolism, 2012
- Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiencyNature Immunology, 2012
- Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII)Neuromuscular Disorders, 2012
- Association of the Congenital Neuromuscular Form of Glycogen Storage Disease Type IV With a Large Deletion and Recurrent Frameshift MutationJournal of Child Neurology, 2011
- Unusual presentation of phosphoglycerate mutase deficiency due to two different mutations in PGAM-M geneNeuromuscular Disorders, 2009
- Treatment recommendations in long‐chain fatty acid oxidation defects: consensus from a workshopJournal of Inherited Metabolic Disease, 2009
- A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiencyMolecular Genetics and Metabolism, 2009
- β‐enolase deficiency, a new metabolic myopathy of distal glycolysisAnnals of Neurology, 2001
- Lipid storage myopathy associated with recurrent Reye syndrome-like attacks, but with a normal carnitine levelBrain and Development, 1988
- Myoadenylate deaminase deficiency in childrenPediatric Neurology, 1985